CDC recommends testing all sexually active monkeypox patients for HIV

The Centers for Disease Control and Prevention yesterday recommended clinicians test all sexually active patients with monkeypox symptoms for HIV and other sexually transmitted infections due to the risk for severe monkeypox in individuals with HIV and other immunocompromising conditions. Among other actions, the agency recommends clinicians consider early treatment with the antiviral drug tecovirimat for immunocompromised patients diagnosed with monkeypox.